Figures computed from official regulatory filings — .
| Insider | Type | Value · USD | Details | |
|---|---|---|---|---|
| PARACKA DANIEL | Other | — | SEC | |
| OtherD (derivative) |
| — |
| SEC |
| SMITH ROBERTS | OtherD (derivative) | — | SEC |
| BORON GREGORY F | OtherD (derivative) | — | SEC |
| COSTA SANTO J | OtherD (derivative) | — | SEC |
| PARACKA DANIEL | OtherD (derivative) | — | SEC |
| PIECZYNSKI JAMES | Other | — | SEC |
| LAMON KIM DAVID | OtherD (derivative) | — | SEC |
| PIECZYNSKI JAMES | OtherD (derivative) | — | SEC |
| DIMITRIADIS ANDRE C | Other | — | SEC |
| DIMITRIADIS ANDRE C | OtherD (derivative) | — | SEC |
| DIMITRIADIS ANDRE C | OtherD (derivative) | — | SEC |
| SMITH ROBERTS | Other | — | SEC |
| BORON GREGORY F | Other | $11.3K | SEC |
| MEL DEUTSCH | OtherD (derivative) | — | SEC |
| SMITH ROBERTS | OtherD (derivative) | — | SEC |
| PIECZYNSKI JAMES | OtherD (derivative) | — | SEC |
| BORON GREGORY F | OtherD (derivative) | — | SEC |
| COSTA SANTO J | OtherD (derivative) | — | SEC |
| COMER WILLIAM M JR | OtherD (derivative) | — | SEC |
| ICN PHARMACEUTICALS INC | Other | $129.6M | SEC |